Back to news

Medline Falls as Investors Weigh Strong Sales Against Profit Quality and 2027 Margin Risks

Investivoq PriceTracker

Medline Inc. (MDLN) is down 5.2% today. Here is some analysis on what might have caused this price movement.

Analysis: The most likely driver is a reassessment of Medline’s earnings quality after last week’s quarterly report. While revenue growth was solid and guidance for organic sales was raised, investors may be focusing on softer reported profit trends, temporary tariff refund benefits, and the risk that next year’s margins look weaker once those benefits fade.

Details:

  • Medline’s third-quarter release showed net sales rose 10.4% to $7.9 billion, but net income slipped 1.2% even as the company lifted full-year organic sales guidance and approved a $1 billion share repurchase program.
  • The quarter included $81 million of net tariff refund benefits, and year-to-date results included $324 million of those benefits, which may be making investors more cautious about how durable current profitability is.
  • Recent filings and earnings materials also listed several cost pressures, including remediation work tied to FDA observations and warning letters, recall and discontinuation costs related to Medline Brand beds, and continuing effects from the Tracy, California distribution-center fire.
  • An analyst note published after earnings lowered its price target and highlighted that fourth-quarter EBITDA guidance sits below market expectations at the midpoint, with additional concern around 2027 tariff and input-cost pressure.

    • Sources:

    SEC, Medline Investor Relations, Investing.com

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $MDLN Insider Trading Activity

    MDLN Insider Trades

    $MDLN insiders have traded $MDLN stock on the open market 27 times in the past 6 months. Of those trades, 1 have been purchases and 26 have been sales.

    Here’s a breakdown of recent trading of $MDLN stock by insiders over the last 6 months:

    • 8 HOLDINGS MOZART MANAGER L.L.C. BCP has made 0 purchases and 4 sales selling 33,317,824 shares for an estimated $1,217,349,994.
    • MOZART ML-2 HOLDCO L.P. BX has made 0 purchases and 4 sales selling 33,317,824 shares for an estimated $1,217,349,994.
    • & FRIEDMAN CAPITAL PARTNERS X (PARALLEL), L.P. HELLMAN has made 0 purchases and 4 sales selling 31,868,237 shares for an estimated $1,164,385,709.
    • PRIVATE LTD GIC has made 0 purchases and 12 sales selling 32,934,513 shares for an estimated $1,154,665,072.
    • DOUGLAS P GOLWAS (Chief Commercial Officer) has made 0 purchases and 2 sales selling 100,000 shares for an estimated $3,677,115.
    • JESSI L CORCORAN (Principal Accounting Officer) purchased 5,000 shares for an estimated $170,750

    To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

    Investivoq Alerts
    Receive MDLN Data Alerts
    Get market-moving data, filings, and signals for MDLN in real time.
    Sign Up

    $MDLN Hedge Fund Activity

    We have seen 276 institutional investors add shares of $MDLN stock to their portfolio, and 204 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • BLACKROCK, INC. added 9,469,927 shares (+56.0%) to their portfolio in Q2 2026, for an estimated $373,493,920
    • LONE PINE CAPITAL LLC added 9,179,211 shares (+77.9%) to their portfolio in Q2 2026, for an estimated $362,028,081
    • CAPITAL RESEARCH GLOBAL INVESTORS added 7,792,738 shares (+19.5%) to their portfolio in Q3 2026, for an estimated $270,408,008
    • DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN added 7,572,176 shares (+172.7%) to their portfolio in Q2 2026, for an estimated $298,646,621
    • WCM INVESTMENT MANAGEMENT, LLC removed 7,397,650 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $256,698,455
    • VIKING GLOBAL INVESTORS LP removed 6,592,912 shares (-57.7%) from their portfolio in Q2 2026, for an estimated $260,024,449
    • MORGAN STANLEY added 5,902,759 shares (+37.6%) to their portfolio in Q2 2026, for an estimated $232,804,814

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $MDLN Price Targets

    Multiple analysts have issued price targets for $MDLN recently. We have seen 2 analysts offer price targets for $MDLN in the last 6 months, with a median target of $45.0.

    Here are some recent targets:

    • Eric Coldwell from Baird set a target price of $45.0 on 06/03/2026
    • Glen Santangelo from Barclays set a target price of $45.0 on 06/01/2026

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.